In a challenging turn for Omega Therapeutics, the biotechnology firm's stock has plummeted to a 52-week low, trading at just $0.44. With a market capitalization of $29.34 million and analyst price ...
BOSTON, Jan. 13, 2025 /PRNewswire/ -- LUB Liquidating Trust (the "Company" or the "Trust"), which was formed to complete the monetization of the assets previously held by Luby's, Inc., announced ...